Medical Oncology

Prof. Dr. Efnan Algın

Doctor and researcher Ankara Bilkent Şehir Hastanesi Ankara
AdenocarcinomaLung NeoplasmsCarcinoma, Non-Small-Cell LungBreast NeoplasmsBrain NeoplasmsEsophageal NeoplasmsStomach NeoplasmsCarcinoma, Renal CellKidney NeoplasmsLiver NeoplasmsPancreatic NeoplasmsOvarian NeoplasmsCarcinoma, Ovarian EpithelialEndometrial NeoplasmsProstatic NeoplasmsGliomaSarcoma, Ewing
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Adenocarcinoma 8 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 6 publications
  • Carcinoma, Non-Small-Cell Lung 5 publications
  • Breast Neoplasms 5 publications
  • Brain Neoplasms 5 publications
  • Esophageal Neoplasms 4 publications
  • Stomach Neoplasms 4 publications
  • Carcinoma, Renal Cell 4 publications
  • Kidney Neoplasms 3 publications
  • Liver Neoplasms 3 publications
  • Pancreatic Neoplasms 3 publications
  • Ovarian Neoplasms 2 publications
  • Carcinoma, Ovarian Epithelial 2 publications
  • Endometrial Neoplasms 2 publications
  • Prostatic Neoplasms 2 publications
  • Glioma 2 publications
  • Sarcoma, Ewing 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • InstitutionAnkara Bilkent Şehir Hastanesisaglik.gov.trFrom source
  • Area of workAdenocarcinomaExtracted from 8 publications · Model version —From source
  • Publications107 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0002-8917-9267ORCIDFrom source
  • Last synchronised5 November 2026 07:23https://ankarasehir.saglik.gov.tr/TR-331078/tibbi-onkoloji-klinigi-doktorlarimiz.html#efnan-alginsaglik.gov.tr

Scientific work

Publications on Adenocarcinoma

107 publications

  1. First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis

    Medicina, 2026

    DOI 10.3390/medicina62050984 PMID 42195237 Open-access full textSource: OpenAlex

  2. Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15041657 PMID 41753346 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Clinicopathological Features of Intrahepatic Cholangiocarcinoma with Assessment of IDH1 Mutation: A Two-Center Retrospective Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15135290 PMID 42452749 Open-access full textSource: ORCID

  4. A Machine Learning Framework for Prognostic Modeling in Stage III Colon Cancer

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15083091 PMID 42074893 Open-access full textSource: ORCID

  5. Association of endoscopic and CT response with pathological response after preoperative FLOT-based therapy for gastric and gastroesophageal junction cancer: a retrospective cohort study

    Frontiers in Oncology, 2026

    DOI 10.3389/fonc.2026.1960800 PMID 42964134 Open-access full textSource: OpenAlex

  6. Abiraterone Acetate Plus Prednisone Induced Bilateral Avascular Necrosis of the Femoral Head

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2025.2025-7-5 Open-access full textSource: OpenAlex

  7. Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma Treated With Second-Line Immunotherapy

    International journal of urology : official journal of the Japanese Urological Association, 2026

    DOI 10.1111/iju.70619 PMID 42655932 Open-access full textSource: Europe PMC

  8. Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer

    Journal of ovarian research, 2026

    DOI 10.1186/s13048-025-01960-4 PMID 42298636 Open-access full textSource: Europe PMC

  9. Prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer: a retrospective cohort study

    Future Oncology, 2026

    DOI 10.1080/14796694.2026.2622299 PMID 41607196 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  10. Neoadjuvant chemotherapy with surgery versus concurrent chemoradiation in N2 non-small cell lung cancer: a retrospective comparative analysis of treatment outcomes

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1837114 Open-access full textSource: OpenAlex

View all 107 publications